Stay updated on Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the DUO-E endometrial cancer study record, including its design, eligibility criteria, outcomes, and supporting documents.
    Difference
    100%
    Check dated 2026-11-08T13:46:09.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the study record content remains unavailable.
    Difference
    0.2%
    Check dated 2026-11-01T14:58:55.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:56:36.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:31:22.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s site revision marker changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T15:10:46.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed, replacing the usual study details with an access-denied message and site chrome. This indicates the page is not accessible at the moment, rather than a substantive update to the study information.
    Difference
    18%
    Check dated 2026-09-20T20:01:57.000Z thumbnail image

Stay in the know with updates to Durvalumab & Olaparib in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Olaparib in Endometrial Cancer Clinical Trial page.